RB1 and cancer: When we review the frequency distribution of samples by RB1/TP53 mutation status in these 76 cancer types, we found in most of these cancer types, the number of RB1/TP53 co-mutants is much larger than the number of samples with RB1 mutation alone whereas there are many more samples with TP53 but not RB1 mutation (Figure 2b).